References
- Brust JC. Acute neurologic complications of drug and alco-hol abuse. Neurologic Clin. N. Am. 1998; 16: 503–519.
- Chung H, Choi H, Kim E, lin W, LeeH, Yoo Y.A fatality due to injection of Tiletamine and Zolazepam, J. Anal. Toxicol. 2000; 24(4): 305–308.
- Cording J, DeLuca R, Camporese T, Spratt E. A fatality related to the veterinary anesthetic Telazol. J. Anal. Toxicol. 1990; 23: 552–555.
- Haas DA, Harper DG. Ketamine: A review of its pharmacologic properties and use in ambulatory anesthesia. Anesth. Prog. 1992; 39: 61–68.
- Hurlburt KM. Drug-induced psychoses. Emerg. Med. Clin. N. Am. 1991; 9: 31–52.
- Jentsch JD, Roth RH. The neuropsychopharmacology of phen-cyclidine: From NMDA receptor hypofunction to the dopaminehypothesisofschizophrenia.Neuropsychopharmacology1999; 20: 201–225.
- Klafta JM, Zacny JP, Young CJ. Neurological and psychiatric adverse effects of anaesthetics. Drug Safety 1995; 13: 281–285.
- Lin HC, Thurmon JC, Benson GJ, Tranquilli VVJ. Telazol - A review of its pharmacology and use in veterinary medicine. J.Vet.Pharmacol.Therap. 1993; 16: 383–418.
- Milhorn HT. Diagnosis and management of phencyclidine intoxication. Am. Family Phys. 43: 1293-1302
- Pablo LS, Bailey JE. Etomidate and telazol. Vet. Clin. N. Am.: Small Anim. Prac. 1999; 29: 779–792 .
- Weiner AL. Emerging drugs of abuse in Connecticut. Con-necticut Med. 64: 19–23.
- Wilson RP, Zagon IS, Larach DR, Lang CM. Cardiovascular and respiratory effects of tiletamine-zolazepam. Pharmacol. Biochem. Behav. 1993; 44: 1–8 .
- Woolf AD. Poisoning by unknown agents. Pediatr. Rev. 1999; 20: 166–170 .
- Quail MT, Weimersheimer P, Woolf AD, Mangnani B. Abuse of telazol: an animal tranquilizer. J. Toxicol. Clin. Toxicol. 2001; 39(4): 399–402.